Intermittent Hypoxia Contributes to the Lung Damage by Increased Oxidative Stress, Inflammation, and Disbalance in Protease/Antiprotease System

Lung

Volumn 194, Issue 6, 2016, Pages 1015-1020

  Tuleta, I ^a   Stockigt F ^a   Juergens, U R ^a   Pizarro, C ^a   Schrickel, J W ^a   Kristiansen, G ^a   Nickenig, G ^a   Skowasch, D ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Antiproteases; Inflammation; Intermittent hypoxia; Oxidative stress; Proteases

Indexed keywords

ALPHA 1 ANTITRYPSIN; CHLORDANE; DESMOSINE; ELASTASE; ELASTIN; GLUTATHIONE; INFLIXIMAB; PROTEINASE; PROTEINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CD68 PROTEIN, MOUSE; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; PANCREATIC ELASTASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; INFLAMMATION; INTERMITTENT HYPOXIA; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; LUNG INJURY; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SLEEP DISORDERED BREATHING; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; COMPLICATION; DRUG EFFECTS; HYPOXIA; LUNG; MACROPHAGE; METABOLISM;

ALPHA 1-ANTITRYPSIN; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIOXIDANTS; DESMOSINE; FEMALE; GLUTATHIONE; HYPOXIA; INFLAMMATION; INFLIXIMAB; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PANCREATIC ELASTASE; REACTIVE OXYGEN SPECIES;

EID: 84991051783     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-016-9946-4     Document Type: Article

References (46)

1. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J (2002) Increased incidence of cardiovascular disease in middle-age men with obstructive sleep apnea: a 7-year follow up. Am J Respir Crit Care Med 166:159–165
2. Broytman O, Braun RK, Morgan BJ, Pegelow DF, Hsu PN, Mei LS, Koya AK, Eldridge M, Teodorescu M (2015) Effects of chronic intermittent hypoxia on allergen-induced airway inflammation in rats. Am J Respir Cell Mol Biol 52:162–170
3. Fortuna AM, Miralda R, Calaf N, González M, Casan P, Mayos M (2011) Airway and alveolar nitric oxide measurements in obstructive sleep apnea syndrome. Respir Med 105:630–636
4. da Rosa DP, Forgiarini LF, Baronio D, Feijó CA, Martinez D, Marroni NP (2012) Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver. Mediat Inflamm 2012:879419
5. Zhang X, Xie M, Gao Y, Wei HH, Zheng JQ (2012) Study on the effect and mechanism of hypoxia on the histological structure of rat’s lung. Sichuan Da Xue Xue Bao Yi Xue Ban 43:1–5. Abstract
6. Aihara K, Oga T, Harada Y, Chihara Y, Handa T, Tanizawa K, Watanabe K, Tsuboi T, Hitomi T, Mishima M, Chin K (2011) Comparison of biomarkers of subclinical lung injury in obstructive sleep apnea. Respir Med 105:939–945
7. Gonchar O, Mankovska I (2012) Moderate hypoxia/hyperoxia attenuates acute hypoxia-induced oxidative damage and improves antioxidant defense in lung mitochondria. Acta Physiol Hung 99:436–446
8. Reinke C, Bevans-Fonti S, Grigoryev DN, Drager LF, Myers AC, Wise RA, Schwartz AR, Mitzner W, Polotsky VY (2011) Chronic intermittent hypoxia induces lung growth in adult mice. Am J Physiol Lung Cell Mol Physiol 300:L266–L273
9. Tuleta I, França CN, Wenzel D, Fleischmann B, Nickenig G, Werner N, Skowasch D (2014) Hypoxia-induced endothelial dysfunction in apolipoprotein E-deficient mice; effects of infliximab and l-glutathione. Atherosclerosis 236:400–410
10. Allahdadi KJ, Walker BR, Kanagy NL (2005) Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 45:705–709
11. Fletcher EC, Orolinova N, Bader M (2002) Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 92:627–633
12. Ward PA (2010) Oxidative stress: acute and progressive lung injury. Ann N Y Acad Sci 1203:53–59
13. Nagai H, Kuwahira I, Schwenke DO, Tsuchimochi H, Nara A, Ogura S, Sonobe T, Inagaki T, Fujii Y, Yamaguchi R, Wingenfeld L, Umetani K, Shimosawa T, Yoshida K, Uemura K, Pearson JT, Shirai M (2015) Pulmonary macrophages attenuate hypoxic pulmonary vasoconstriction via β3AR/iNOS pathway in rats exposed to chronic intermittent hypoxia. PLoS ONE 10:e0131923
14. He C, Ryan AJ, Murthy S, Carter AB (2013) Accelerated development of pulmonary fibrosis via Cu, Zn-superoxide dismutase-induced alternative activation of macrophages. J Biol Chem 288:20745–20757
15. Groutas WC, Dou D, Alliston KR (2011) Neutrophil elastase inhibitors. Expert Opin Ther Pat 21:339–354
16. Chua F, Laurent GJ (2006) Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. Proc Am Thorac Soc 3:424–427
17. Kalsheker N, Morley S, Morgan K (2002) Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem Soc Trans 30:93–98
18. Speer CP, Ninjo A, Gahr M (1986) Elastase-alpha 1-proteinase inhibitor in early diagnosis of neonatal septicemia. J Pediatr 108:987–990
19. Zuo L, Pannell BK, Zhou T, Chuang CC (2016) Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications. Gene. doi:10.1016/j.gene.2016.01.004
20. Brantly M (2002) Alpha1-antitrypsin: not just an antiprotease: extending the half-life of a natural anti-inflammatory molecule by conjugation with polyethylene glycol. Am J Respir Cell Mol Biol 27:652–654
21. Sarıman N, Levent E, Cubuk R, Yurtlu S, Benli Aksungar F (2011) Bronchial hyperreactivity and airway wall thickening in obstructive sleep apnea patients. Sleep Breath 15:341–350
22. Gilutz H, Siegel Y, Paran E, Cristal N, Quastel MR (1983) Alpha 1-antitrypsin in acute myocardial infarction. Br Heart J 49:26–29
23. Brunetti ND, Correale M, Pellegrino PL, Cuculo A, Biase MD (2007) Acute phase proteins in patients with acute coronary syndrome: correlations with diagnosis, clinical features, and angiographic findings. Eur J Intern Med 18:109–117
24. Zhao H, Liu H, Chai L, Xu P, Hua L, Guan XY, Duan B, Huang YL, Li YS (2015) Plasma α1-antitrypsin: a neglected predictor of angiographic severity in patients with stable angina pectoris. Chin Med J (Engl) 128:755–761
25. Linja-Aho A, Mazur W, Toljamo T, Nieminen P, Ohlmeier S, Rönty M, Kinnula VL (2013) Distribution and levels of alpha-1-antitrypsin in the lung and plasma in smokers and chronic obstructive pulmonary disease. APMIS 121:11–21
26. Seddon J, Kasprowicz V, Walker NF, Yuen HM, Sunpath H, Tezera L, Meintjes G, Wilkinson RJ, Bishai WR, Friedland JS, Elkington PT (2013) Procollagen III n-terminal propeptide and desmosine are released by matrix destruction in pulmonary tuberculosis. J Infect Dis 208:1571–1579
27. Laguna TA, Wagner BD, Starcher B, Luckey Tarro HK, Mann SA, Sagel SD, Accurso FJ (2012) Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation. Pediatr Pulmonol 47:856–863
28. Fiorenza D, Viglio S, Lupi A, Baccheschi J, Tinelli C, Trisolini R, Iadarola R, Luisetti M, Snider GL (2002) Urinary desmosine excretion in acute exacerbations of COPD: a preliminary report. Respir Med 96:110–114
29. Monaco C, Nanchahal J, Taylor P, Feldmann M (2015) Anti-TNF therapy: past, present and future. Int Immunol 27:55–62
30. Kurt A, Tumkaya L, Turut H, Cure MC, Cure E, Kalkan Y, Sehitoglu I, Acipayam A (2015) Protective effects of infliximab on lung injury induced by methotrexate. Arch Bronconeumol 51:551–557
31. Starkhammar M, Kumlien Georén S, Dahlén SE, Cardell LO, Adner M (2015) TNFα-blockade stabilizes local airway hyperresponsiveness during TLR-induced exacerbations in murine model of asthma. Respir Res 16:129
32. Altintas N, Erboga M, Aktas C, Bilir B, Aydin M, Sengul A, Ates Z, Topcu B, Gurel A (2015) Protective effect of infliximab, a tumor necrosis factor-alpha inhibitor, on bleomycin-induced lung fibrosis in rats. Inflammation 39:65–78
33. Vorselaars AD, Crommelin HA, Deneer VH, Meek B, Claessen AM, Keijsers RG, van Moorsel CH, Grutters JC (2015) Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis. Eur Respir J 46:175–185
34. Domej W, Oettl K, Renner W (2014) Oxidative stress and free radicals in COPD—implications and relevance for treatment. Int J Chronic Obstr Pulm Dis 9:1207–1224
35. Younes M, Strubelt O (1990) Protection by exogenous glutathione against hypoxic and cyanide-induced damage to isolated perfused rat livers. Toxicol Lett 50:229–236
36. Matera MG, Calzetta L, Cazzola M (2016) Oxidation pathway and exacerbations in COPD: the role of NAC. Expert Rev Respir Med 10:89–97
37. Gould NS, Min E, Huang J, Chu HW, Good J, Martin RJ, Day BJ (2015) Glutathione depletion accelerates cigarette smoke-induced inflammation and airspace enlargement. Toxicol Sci 147:466–474
38. Bedreag OH, Rogobete AF, Sarandan M, Cradigati AC, Papurica M, Dumbuleu MC, Chira AM, Rosu OM, Sandesc D (2015) Oxidative stress in severe pulmonary trauma in critical ill patients. antioxidant therapy in patients with multiple trauma–a review. Anaesthesiol Intensive Ther 47:351–359
39. Farías JG, Zepeda AB, Calaf GM (2012) Melatonin protects the heart, lungs and kidneys from oxidative stress under intermittent hypobaric hypoxia in rats. Biol Res 45:81–85
40. Budhiraja R, Siddiqi TA, Quan SF (2015) Sleep disorders in chronic obstructive pulmonary disease: etiology, impact, and management. J Clin Sleep Med 11:259–270
41. Dudley KA, Malhotra A, Owens RL (2014) Pulmonary Overlap Syndromes, with a focus on COPD and ILD. Sleep Med Clin 9:365–379
42. McNicholas WT, Verbraecken J, Marin JM (2013) Sleep disorders in COPD: the forgotten dimension. Eur Respir Rev 22:365–375
43. Olea E, Ferrer E, Prieto-Lloret J, Gonzalez-Martin C, Vega-Agapito V, Gonzalez-Obeso E, Agapito T, Peinado V, Obeso A, Barbera JA, Gonzalez C (2012) Effects of cigarette smoke and chronic hypoxia on ventilation in guinea pigs clinical significance. Adv Exp Med Biol 758:325–332
44. Wu W, Dave NB, Yu G, Strollo PJ, Kovkarova-Naumovski E, Ryter SW, Reeves SR, Dayyat E, Wang Y, Choi AM, Gozal D, Kaminski N (2008) Network analysis of temporal effects of intermittent and sustained hypoxia on rat lungs. Physiol Genomics 36:24–34
45. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T (2008); American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology; American Heart Association Stroke Council; American Heart Association Council on Cardiovascular Nursing; American College of Cardiology Foundation. Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118:1080–1111
46. Diogo LN, Monteiro EC (2014) The efficacy of antihypertensive drugs in chronic intermittent hypoxia conditions. Front Physiol 5:361